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Background. Depression and anxiety are major causes of absence from work and underperformance in the workplace.
Cognitive behavioural therapy (CBT) can be effective in treating such problems and online versions offer many practical
advantages. The aim of the study was to investigate the effectiveness of a computerized CBT intervention (MoodGYM) in
a workplace context.
Method. The study was a phase III two-arm, parallel randomized controlled trial whose main outcome was total
score on the Work and Social Adjustment Scale (WSAS). Depression, anxiety, psychological functioning, costs and
acceptability of the online process were also measured. Most data were collected online for 637 participants at baseline,
359 at 6 weeks marking the end of the intervention and 251 participants at 12 weeks post-baseline.
Results. In both experimental and control groups depression scores improved over 6 weeks but attrition was high. There
was no evidence for a difference in the average treatment effect of MoodGYM on the WSAS, nor for a difference in any of
the secondary outcomes.
Conclusions. This study found no evidence that MoodGYM was superior to informational websites in terms of psycho-
logical outcomes or service use, although improvement to subthreshold levels of depression was seen in nearly half the
patients in both groups.
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Introduction
Depression and anxiety are recognized as major causes
of work underperformance and absence (Sanderson
et al. 2007). Up to 9% of the UK population is likely
to be affected by these treatable mental health issues
(Singleton et al. 2001) that make an impact directly
on the productivity of the labour force. Yet a survey
of employers in 2009 found that only 22% had mental
health policies in place, and concluded that ‘people
with mental health disorders are unlikely to avoid
prejudices in the workplace’ (Trajectory, 2010). This
could discourage appropriate help-seeking.
Computerized interventions can be provided con-
sistently to large numbers of people and appear more
acceptable to individuals who regard formal mental
health services as stigmatizing. They are less costly
than face-to-face therapy and easy to access thanks to
the growing use of the Internet. Two computerized
cognitive behavioural therapy (cCBT) packages re-
ceived approval from the National Institute for
Clinical Excellence (NICE, 2006): one for panic and
phobia (Fearﬁghter) and one for mild and moderate
depression (Beating the Blues). Primary care providers
in England and Wales were then instructed by NICE to
make cCBT available to all patients (Department of
Health, 2007).
Evidence about these and other cCBT packages
remains promising but inconclusive, making it desir-
able to investigate the costs and beneﬁts of each pack-
age in relation to speciﬁc diagnostic groups (Sarrami
et al. 2011). With the exception of one small trial in
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the National Health Service (NHS) of Beating the Blues
(Grime, 2004), at the outset of the present trial we
could ﬁnd no published studies of cCBT in workplace
settings. That study found that Beating the Blues was
beneﬁcial for depression and anxiety at 1 month,
but not at 3 and 6 months post-treatment. However,
there are considerable differences between the earlier
study and the present one: participants in Grime’s
study (Grime, 2004) accessed the programme via a per-
sonal computer in a private room in their occupational
health department, a relatively controlled context,
while in the present study a different programme
(MoodGYM) was tested, accessed via the Internet
from any location.
Aim
The aim of the study was, through a pragmatic trial in
the workplace, to measure the impact of an interactive
cCBT programme (MoodGYM) on employees’ work-
related performance and psychological well-being,
compared with that of an ‘attentional’ control (ﬁve
websites with general information about mental
health). The main hypothesis was that users of
MoodGYM would experience less functional impair-
ment at work than the control group.
Method
Design and data collection
The study was a two-arm, parallel randomized
controlled trial with a 5-week intervention period
and follow-up at 6 and 12 weeks. The trial (no.
ISRCTN24529487; http://www.controlled-trials.com/)
was designed to be administered mainly online. The
MoodGYM developers were commissioned by the
study investigators to construct a research portal that
could allocate login identities, screen, take consent,
randomize and direct participants to the appropriate
arm of the study. This issued emails that prompted
participants to complete assessments at 6 and
12 weeks. The trial manager could be contacted by
email in case of problems, such as forgotten pass-
words. The portal was piloted in June–September
2009, and following revisions to the website the trial
was launched in November 2009. The trial portal was
closed to new recruits on 31 May 2011.
Occupational health sections of three large em-
ployers agreed to participate in the trial, by directing
their staff to the website and promoting the oppor-
tunity internally. The workplaces were thus a con-
venience sample, which spanned, as it turned out,
the transport, health and communications sectors.
Employees were given conﬁdential access to the trial
website. Online screening of potential participants
offered the option of joining the trial if they were
aged over 18 years and met the following criterion:
on the Patient Health Questionnaire-9 (PHQ-9;
Kroenke & Spitzer, 2002) the employee scored 2 or
more on ﬁve of the nine items, including 2 or more
on item 1 (little interest in doing things) or item 2 (feel-
ing hopeless). To be eligible the employee also had to
conﬁrm that at least one of the items identiﬁed as a
problem for them made it difﬁcult to work, take care
of things at home, or get along with other people.
All participants were required to give a telephone
number as a condition of joining the study. Weekly
telephone calls were made, lasting about 10min on
average, with three purposes: to maintain engagement
with the study; to screen for risk; and to collect service
use data for costing purposes. The telephone input
was provided to both arms of the trial by the Mental
Health Research Network’s clinical studies ofﬁcers,
who made up to ﬁve calls before recording a non-
response.
Interventions
MoodGYM is a freely available course developed at
Australia National University (ANU) which allows
participants to proceed at their own pace over ﬁve,
1 h-long modules, usually taken weekly (ANU, 2012).
The websites selected for the control group were
judged from a previous review of self-help in mental
health to be reliable sources of information about men-
tal health problems, and are listed in Table 1.
Risk of adverse events
The telephone interviewers also screened for risk of
self-harm or suicide, and followed a protocol which
Table 1. Website links sent weekly to participants in the
control arm
Website address
Title on
trial portal
http://www.hse.gov.uk/stress Stress at work
http://www.nhs.uk/Conditions/
Mental-health/Pages/Introduction.
aspx?url=Pages/What-is-it.aspx
NHS Choices:
mental health
http://www.mentalhealth.org.uk/
information/mental-health-a-z/
A to Z of mental
health problems
http://www.bbc.co.uk/health/conditions/
mental_health/emotion_stress.shtml
Tackling stress
http://www.rethink.org/living_with_
mental_illness/rights_and_laws/index.
html
Your rights to care
and treatment
NHS, National Health Service.
742 R. Phillips et al.
permitted them to breach conﬁdentiality if participants
seemed so unwell that immediate professional care
was indicated but they were unwilling or unable to
access this without assistance. This was invoked
twice. In addition, participants were told at the outset
and reminded periodically in the telephone interviews
that they should consult their general practitioner (GP)
or occupational health department (as appropriate for
each organization) if they had intentions to harm them-
selves. On six occasions telephone interviewers con-
tacted the relevant emergency contact with the
client’s permission.
Ethical oversight
A favourable ethical opinion was granted by
Derbyshire Local Research Ethics Committee on 6
January 2009. The Mental Health Research Network
adopted the study in February 2009. ANU’s ethics
committee also approved the study before the portal
was piloted.
Sample size
The power calculation was designed to detect a mean
difference of 3 points on the Work and Social
Adjustment Scale (WSAS; Mundt et al. 2002). This
3-point difference is judged to be clinically signiﬁcant
on the basis of the ﬁndings from Proudfoot et al.
(2004) where outcomes for intervention participants
were consistently at least 3 points lower on the
WSAS than for the treatment-as-usual participants.
With an assumed standard deviation of 9 (rounded
up from 8.4 in the same study) and 80% power at a
5% signiﬁcance level, we required 142 participants
per arm to complete the study. Assuming a drop-out
of 20%, a total of 355 participants was required.
Based on estimates of withdrawal, refusal and loss to
the study on a previous large trial of MoodGYM
(Mackinnon et al. 2008) it was anticipated that 60% of
those eligible to participate would be retained over
6 months. To achieve a ﬁnal sample of 355, recruitment
of 592 participants was anticipated.
Randomization and blinding
A list was produced by the Nottingham Clinical Trials
Unit to allow simple (unrestricted) randomization
(Schulz & Grimes, 2002). Once potential participants
had completed the screening questions, if eligible for
inclusion in the trial, they were given a study ID, allo-
cated through the website, and they were then invited
to join the trial. If participants consented, they were
randomized by the portal designers at ANU. In this
way the randomization status of participants was
concealed from their employers and from the research
team until the study was completed.
The study design aimed to be double-blind.
Participants were told that they were participating in
a trial of ‘online self-help’, comparing two approaches,
and researcher bias was avoided completely because
most data for the outcome measures were collected
online. However, the telephone interviewers who
recorded service use measures for economic analysis
were not blind to the randomization status of the
participants.
Measures
Outcomes
The WSAS (Mundt et al. 2002) was used to measure the
primary outcome: subjective, work-related perform-
ance. Besides having face validity in relation to
employers’ concerns, given the workplace focus of
this trial, the WSAS is a brief, reliable and valid test,
which has high correlations between clinician and self-
report versions (Mundt et al. 2002). These consider-
ations made the WSAS suitable for this study, in
which online data collection and self-reporting were
intended. The WSAS scale ranges from 0 to 40, with
higher scores indicating more disability. It rates
responses 0 (‘not at all’) to 8 (‘very severely’), and
states: ‘People’s problems sometimes affect their ability
to do certain day-to-day tasks in their lives. To rate
your problems look at each section and determine on
the scale provided how much your problem impairs
your ability to carry out the activity.’ The ﬁve items
are work, home management, social leisure activities,
private leisure activities, and family and relationships.
Secondary outcomes rated were: depression, using
the PHQ-9 (Kroenke & Spitzer, 2002); Clinical
Outcomes in Routine Evaluation (CORE10; Evans
et al. 2002); and generalized anxiety disorder (GAD;
Spitzer et al. 2006). Advantages of the PHQ-9 include
its brevity and its construct and criterion validity. In
addition to measuring diagnostic thresholds, the
PHQ-9 can assist in estimating the severity of depress-
ive disorders. Scores on the PHQ-9 range from 0 to 27,
with higher scores indicating more depressive symp-
toms.
The CORE10 score can range from 0 to 40, with
higher scores indicating that individuals are reporting
more problems and experiencing more distress. The
GAD score can range from 0 to 21, with higher scores
indicating greater anxiety. Health-related quality of life
was measured with the ﬁve-domain EuroQol (EQ-5D;
Brooks et al. 1991). Each of the ﬁve domains (mobility,
self-care, usual activities, pain/discomfort, anxiety/
depression) is rated as 1 (no problem), 2 (moderate
problems) or 3 (major problems).
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Other measures included were self-assessed absence
from work and acceptability of the online process.
Service use [Client Service Receipt Inventory (CSRI);
Beecham & Knapp, 2001] and quality of life (EQ-5D)
were measured to permit cost-effectiveness analysis,
reported here.
Demographic information
All those individuals who consented to participate pro-
vided basic demographic data online: gender, age,
marital status, alcohol consumption, education and
details of their employment.
Service use and sick leave
Telephone interviewers recorded the use of health and
social care services by study participants with an
adapted version of the CSRI, incorporating additional
questions regarding lost employment: ‘In the past six
months/week have you had any days off due to ill-
health?’ and ‘If so, how many of these days would
you say were due to your mental health?’
Statistical analysis
Sample proﬁle
The characteristics of the trial participants were com-
pared with the whole workforce for each organization
involved in the trial. The demographics of participants
who completed screening and chose to proceed were
compared with those who completed screening and
did not proceed, and those who completed follow-ups
were compared with non-completers. The sensitivity of
the results of the main analysis to possible bias deriv-
ing from gender imbalance and drop-out was
explored. We also investigated variation in partici-
pants’ engagement with MoodGYM.
Loss to follow-up and other missing data
Where no more than 20% of items were missing, base-
line items were imputed using the mean response to
the valid questionnaire items. The WSAS data were
complete at baseline so no imputation was performed.
For the CORE10, PHQ-9 and GAD we imputed the
total score based on the mean score of the valid
responses; if less than 80% items were answered then
the total was left missing. No imputation was con-
ducted on outcome scores.
Main analysis
Data were analysed using Stata 11.2 (Timberlake
Consultants, UK) according to the intention-to-treat
principle; patients’ data were analysed in the treatment
groups to which they were randomized irrespective of
treatment received as long as outcome data were avail-
able, including imputed baseline data as determined
above.
The main research question was addressed by a
single statistical model to estimate the difference in
mean outcome (WSAS) of scores between participants
randomized to MoodGYM and control across the two
follow-up points (6 and 12 weeks). A double-sided
5% signiﬁcance level was used for this analysis. No
multiple testing adjustments were made to the signiﬁ-
cance level for the other analyses, which are regarded
as exploratory.
A linear, mixed-effect model for longitudinal data
(random intercept model) was used to estimate,
using maximum likelihood, the difference between
treatment arms in WSAS score at 6 and 12 weeks over-
all (taking account of any time trends). This approach
allowed the simultaneous modelling of the two
follow-up time points, thus reﬂecting the estimated
difference in randomized groups across the entire
follow-up period. This permitted us to use the data
from follow-up assessments at both time points
and to take account of the impact of time on the
participants’ outcomes.
The assumption of normality for the residuals was
checked visually from probability plots. All partici-
pants with outcome data available were included in
all models, whether they completed both 6- and
12-week follow-ups, or only one.
The pre-speciﬁed covariates that were included in
the model consisted of the baseline outcome score,
the randomization group and the organization. Time
was included to estimate the time trends over the
whole sample. An interaction between time and inter-
vention was also tested for evidence of a differential
effect over time.
Baseline variables that were associated with missing
outcomes were investigated so that they could be
included in models and minimize bias due to non-
response.
Exception to the protocol
Due to a technical error in the research portal, a num-
ber of individuals who had more severe mental health
problems were not excluded as the protocol intended.
A total of 101 individuals who consented to participate
were subsequently found to have brain injury or stroke
or to be receiving CBT or treatment for bipolar dis-
order. Instead of being excluded by the portal,
67 went on to register as part of the trial, and 41 con-
tinued to complete the baseline measures and were
therefore randomized (22 to MoodGYM and 19 to
the control arm), 23 completed the 6-week follow-
up quiz and 20 completed the 12-week follow-up.
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When this error came to light it was the subject of con-
siderable discussion; the research team’s decision was
to retain in the sample the individuals who gave
their data in good faith, that this was consistent with
the trial’s pragmatic design and the most ethical way
to proceed. We fully explored the impact of this
decision on the results and found that, while the
mean WSAS score was higher for this subgroup of par-
ticipants with more severe mental health problems,
there were no differences on the other baseline vari-
ables and their inclusion in the ﬁnal analyses made
no difference to the results of the analyses.
Economic analysis
Costs were calculated by combining the service use
data with information on unit costs (Curtis, 2010).
Lost employment was valued by combining lost work
days with average earnings data. Costs at follow-up
with and without lost employment were compared
between the two groups. Due to expected skewness in
the cost distribution, a bootstrapped regression model
was used, with baseline costs controlled for.
Quality adjusted life years (QALYs) were computed
from the EQ-5D by converting the ﬁve domain scores
to previously established weights (Dolan et al. 1995)
and using area under the curve methods. If the inter-
vention results in lower costs and better outcomes
then it is deemed ‘dominant’. If it, or the control, had
both higher costs and better outcomes then an incre-
mental cost-effectiveness ratio is calculated, deﬁned
as the difference in costs divided by the difference in
QALYs. This shows the extra cost incurred to produce
an extra QALY.
Results
Recruitment and representativeness of recruited
participants
Participant ﬂow through the trial is summarized in a
consort diagram in Appendix 1. There were 9305 visits
to the website, 1111 completed the screening and 637
were randomized, with 359 completing 6-week online
assessments and 231 participants completing 12-week
online assessments. The research portal was ﬁrst
piloted with organization A (communications sector),
and then implemented incrementally there. It was pro-
moted using internal communications and regular tele-
phone conferences with key personnel over the
duration of the study (2 years). Organization B (trans-
port sector) joined the trial a few months later and pro-
moted it through their intranet as well as referring
individuals through the in-house counselling service,
so offering it to employees who were deemed likely
to beneﬁt as well as to the wider workforce.
After 1 year in the ﬁeld, trial recruitment was lagging,
so we recruited organization C (health sector) to the
study in October 2010. This entailed making access
available on their website, with minimal marketing.
The recruitment numbers reﬂect the size of the
employers and the nature of the workforces as well
as the extent to which the study was actively pro-
moted. At baseline assessment, organization A
recruited 396 (62%), B recruited 100 (16%), and C
recruited 141 participants (22%). Since the trial was
open for different periods to each workplace, and
Internet use is likely to vary between occupational set-
tings, with high use in communications employees
compared with transport employees, rates of recruit-
ment cannot be compared meaningfully.
Demographic comparisons
Table 2 shows the baseline demographic information
according to trial arm. More males were randomized
to control than MoodGYM; a sensitivity analysis there-
fore adjusted for gender. The occupational groups who
participated in the study shown in Table 2 are not
representative of their employers, nor of the personnel
experiencing stress in each setting; they merely reﬂect
the individuals who took up the trial opportunity.
Clinical outcomes and missing data
We had data at one or more assessment points over the
12 weeks for 401 subjects (63%). Our primary outcome
(WSAS scale) was completed by 636/637 subjects at
baseline – the subject who failed to complete the base-
line questionnaire was randomized and did complete
the 6- and 12-week follow-ups as well as the
MoodGYM modules. Completion was 359/637 (56%)
at 6 weeks and 231/637 (36%) at 12 weeks.
As seen from these numbers, the completion rate of
the initial 637 participants was low. We therefore com-
pared the characteristics of completers with non-
completers at both 6 and 12 weeks to see if there
were any obvious differences between those who pro-
ceeded through the study and those who dropped out
at 6 or 12 weeks. At 6 weeks the proportion completing
follow-up was higher for the control arm but this
difference was not statistically signiﬁcant. The pro-
portion of completers was higher in the transport sec-
tor workplace than in the health or communications
workplaces; the ﬁnding was statistically signiﬁcant
but the differences were small. The only other
ﬁnding of note was that the difference in ages was stat-
istically signiﬁcant; completers were marginally older.
However, again, this difference was very small. Com-
parisons of the demographic information between
completers and non-completers at 12 weeks revealed
very similar patterns to the 6-week comparisons.
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Baseline psychiatric scores were marginally lower in
participants who completed the 6-week follow-up;
these small differences were statistically signiﬁcant.
The same pattern was present at 12 weeks, apart
from the WSAS score that showed that the non-
completers had a marginally lower baseline WSAS
score than the completers. However, none of these
differences was statistically signiﬁcant at 12 weeks.
Adherence to the experimental intervention
Each participant on MoodGYM should complete ﬁve
modules, so to investigate adherence they were
assigned a score from 0 to 4 to indicate the level of
completion for each of these modules (0=0%, 1=25%,
2=50%, 3=75% and 4=100%). Thus each participant
could score up to 20, and by inspecting the distribution
of scores we found that the participants clustered into
‘high’ (9–20, n=90), ‘medium’ (4–8, n=117) and ‘low’
(0–3, n=106) completion groups. We found no signiﬁ-
cant differences in the age, gender, marital status,
median years of education or median units of alcohol
consumed across high and low completion groups. It
appears that those that completed the highest level of
MoodGYM modules were marginally older but this
difference was not statistically signiﬁcant. There does
not appear to be a signiﬁcant difference in the median
years of education or median units of alcohol con-
sumed across the groups. Married individuals were
over-represented in the high completion category com-
pared with single/widowed/divorced – but this trend
was not signiﬁcant.
Primary analysis
Table 3 shows the outcome scores by treatment arm at
three time points. Means in both treatment arms
decreased on each of the psychiatric measures. Fig. 1
illustrates the proﬁle of the unadjusted means for the
WSAS score. Adjusting for covariates (time, baseline
score and organization) made little difference to the
proﬁle.
In the random-effects model, which combines data
from 6 and 12 weeks to give a combined effect size,
Table 2. Characteristics of subjects according to study arm
Control
(n=319)
MoodGYM
(n=318)
Gender
Male 160 (50) 136 (43)
Female 152 (48) 176 (55)
Missing 7 (2) 6 (2)
Mean age, years (S.D.) 42.7 (9.6) 42.2 (9.6)
Marital status
Single 82 (26) 67 (21)
Married/cohabiting 196 (61) 218 (69)
Widowed/separated 34 (11) 27 (8)
Missing 7 (2) 6 (2)
Organizationa
A 195 (61) 198 (62)
B 51 (16) 49 (15)
C 73 (23) 71 (22)
Occupation
Manager or senior ofﬁcial 92 (29) 91 (29)
Professional 66 (21) 63 (20)
Associate professional or technical 33 (10) 32 (10)
Administrative and secretarial 34 (11) 52 (16)
Skilled trade 14 (4) 5 (2)
Personal services 0 (0) 2 (1)
Sales and customer service 60 (19) 61 (19)
Process, plant and machine operative 1 (0.3) 1 (0.3)
Other 19 (6) 10 (3)
Missing 0 (0) 1 (0.3)
S.D., Standard deviation.
Data are given as numbers (%) of subjects unless stated otherwise.
a A=communications sector; B= transport sector; C=health sector.
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there was no statistically signiﬁcant difference in the
average treatment effect on the WSAS score over the
two time points. Also there was no evidence for an
interaction between time point and intervention, and
so no evidence of a differential effect over time (justify-
ing the combination of the estimate of the effect over
the two time points). This model adjusted for baseline
WSAS score and organization. For the WSAS score the
estimated treatment effect across follow-ups was –0.47
(95% CI –1.84 to 0.90, p=0.5). There was no evidence to
support a difference in the intervention effect accord-
ing to employer (we tested for interaction). Nor was
there evidence of a statistically signiﬁcant treatment
effect for any of the secondary outcomes.
We then compared the model for our primary analy-
sis with two additional models, one to account for a
possible gender imbalance at baseline, and another to
control for any variables that were associated with
missing follow-ups. Analysis showed that the follow-
ing variables were associated with not completing
follow-ups: age, organization and baseline psychiatric
scores. These analyses did not give us any reason to
alter our main ﬁnding that there was no evidence of
a difference in effect between MoodGYM and control.
There was no difference in primary outcome scores at
6 weeks for those who completed both follow-ups
compared with those who only completed the 6-
week follow-up (16.29 v. 16.28, respectively)
It was decided at the beginning of the study that the
primary analysis would include both time points.
Table 3. Comparison of intervention groups for primary and secondary outcome measures
Outcome
Control MoodGYM
Treatment effecta,b (95% CI); pn Mean (S.D.) n Mean (S.D.)
Primary
WSAS
Baseline 319 20.0 (7.7) 317 19.9 (8.0) −0.470 (–1.837 to 0.897); 0.50
6 weeks 188 16.5 (8.6) 171 16.0 (9.1)
12 weeks 129 15.9 (8.6) 102 15.0 (10.1)
Secondary
PHQ-9c −0.429 (–1.454 to 0.595); 0.41
Baseline 318 14.6 (5.6) 311 14.6 (5.4)
6 weeks 176 10.2 (6.0) 164 9.9 (6.1)
12 weeks 122 10.3 (6.9) 97 9.3 (6.9)
CORE10
Baseline 318 18.3 (5.3) 316 18.4 (5.9) −0.257 (–1.244 to 0.731); 0.61
6 weeks 187 15.3 (6.1) 171 15.3 (6.1)
12 weeks 129 15.0 (6.9) 101 14.1 (7.3)
GAD −0.341 (–1.334 to 0.651); 0.50
Baseline 305 13.2 (5.0) 303 13.0 (5.4)
6 weeks 181 10.2 (5.7) 166 9.5 (6.0)
12 weeks 123 10.1 (6.5) 98 8.4 (6.4)
S.D., Standard deviation; CI, conﬁdence interval; WSAS, Work and Social Adjustment Scale; PHQ-9, Patient Health
Questionnaire-9; CORE10, Clinical Outcomes in Routine Evaluation; GAD, generalized anxiety disorder.
a MoodGYM minus control, based on 6 and12 weeks combined, adjusted for time, baseline value of outcome
and organization.
b Refers to the estimated mean difference, across both time points.
c Threshold for inclusion in the study was PHQ-9 score 510.
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Fig. 1. Box plots of Work and Social Adjustment Scale
(WSAS) scores at each time point for the two trial arms.
Data represent mean, interquartile range, minimum and
maximum.
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However, at the end of the study when we could see
that attrition was very large we re-ran the analysis
exploring the differences between baseline and
6 weeks for exploratory purposes. The results of this
did not change our conclusions.
Economic results
There were no major differences in costs between the
two groups at baseline. As shown in Table 4, in the
6 months prior to randomization at least two-thirds
of subjects had GP contacts and one in ﬁve attended
hospital as an out-patient. A similar proportion –
about one-ﬁfth of participants, used some kind of
community-based provider. Most were in receipt of
psychotropic medication: antidepressants and anxio-
lytics. During the 6-week follow-up period, there
were no major differences in service use between the
groups. Note that the baseline and follow-up costs
relate to different time periods.
At baseline, aroundhalf the sample had taken time off
work due to sickness, on average about 20 days over
6 months. Respondents stated that most of this time
(52%) was taken off due to their mental health, which
affected 28% of employees. Participants who were
absent for this reason took longer on average to return
to work – about 28 days. About 16% of participants
took some time off sick during the study period – on
average 7 days.Most of this sick leave (9% of employees,
56% of those off work) was attributed to mental health
difﬁculties, and again the average length of absence
was longer than for other health reasons: 11 days.
The cost of lost employment was higher for the con-
trol group at follow-up (£111 v. £96, a difference of
2 days on average over all participants during the
5-week follow-up period). However, this did not attain
statistical signiﬁcance (t test of independent means:
p=0.759, 95% CI –126 to 92). A similar pattern was
seen in the total costs of absence fromwork, where con-
trol participants had higher costs (£143 v. £119) but this
was not signiﬁcant (p=0.644, 95% CI –137 to 84).
Over the ﬁrst 6 weeks of the follow-up there was
virtually no difference in QALYs gained (0.082
MoodGYM, 0.083 control). Over the 12 weeks the
gains were 0.170 and 0.167, respectively. In terms of
point estimates, MoodGYM resulted in slightly lower
costs but a slightly lower QALY gain. However, the
uncertainty around the estimates is suggestive of no
apparent difference in cost-effectiveness between the
groups.
Discussion
Most subjects participating in both arms of the trial
improved over time and returned to work. Compared
with the control group outcomes, MoodGYM was not
associated with greater improvement in health or qual-
ity of life over the follow-up period. Both arms
received regular telephone calls to collect data and
divert participants at risk; this constant should be
borne in mind when interpreting the results. It is poss-
ible that merely receiving a weekly telephone call con-
cerning one’s service use and symptoms had beneﬁcial
effects, irrespective of whether participants used the
online resources, although Christensen et al. (2004)
found a difference between telephone-only controls
and a self-selected intervention group. The lack in the
current study of a control group that received no direct
human contact of any kind means that this cannot be
ruled out. An alternative explanation might be a pla-
cebo effect from Internet use; a further control group
not exposed to any form of Internet use would be
required to test this, but that is not consistent with
the pragmatic design of this trial.
It is difﬁcult to distinguish the immediate cause of
any given period of sickness absence. In this study
we simply asked the participants to tell us if their
time off was due to their mental health, and indeed
this was the attribution of most of the time off which
was reported, both in the 6 months preceding the
study and during the 5-week intervention period.
Although not statistically signiﬁcant, and with sub-
stantial variation about the mean, average sick leave
absence of two additional days over 5 weeks for the
control group extrapolates to an additional 4 weeks’
absence per annum. While this could well be a chance
ﬁnding, it may be taken as grounds for further
investigation.
A notable aspect of this study is its approach to
recruitment, screening and participation online,
whose potential applications in clinical research have
yet to be fully realised. This proved challenging and
instructive. The experience gained in this trial has
helped to build capacity for future studies and advance
knowledge around beneﬁts and obstacles of trial
implementation through the Internet. Besides cost
efﬁciency, online data collection offers the ability to
involve people from anywhere in the world, rigorously
consistent delivery of designated interventions, a cer-
tainty that consent is genuine and on-going, and mini-
mal researcher bias, since the research team had no
contact with the participants.
Limitations
Despite telephone calls and email prompts to complete
assessment tools, the retention rate from this study
(56% at 6 weeks, 36% at 12 weeks) was low by com-
parison with studies where there is face-to-face contact
between the participant and the research team. This
and the relatively short follow-up period are the
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Table 4. Service use and costs at baseline and 6-week follow-up
Service
Baseline Follow-up
MoodGYM intervention Control MoodGYM intervention Control
Participants
using, n (%)
Mean cost, all
participants, UK£
(S.D.)
Participants
using, n (%)
Mean cost, all
participants, UK£
(S.D.)
Participants
using, n (%)
Mean cost, all
participants, UK£
(S.D.)
Participants
using, n (%)
Mean cost, all
participants, UK£
(S.D.)
Hospital services
In-patient 20 (6) 101 (854) 27 (8) 345 (3733) 2 (1) 3 (46) 2 (1) 1 (22)
Out-patient 61 (19) 90 (748) 73 (23) 77 (315) 22 (7) 11 (73) 30 (9) 25 (118)
Community services
GP 225 (71) 98 (187) 213 (67) 88 (130) 74 (23) 6 (17) 82 (26) 7 (18)
Psychiatrist 14 (4) 42 (484) 4 (1) 5 (52) 5 (2) 4 (38) 4 (1) 1 (10)
District nurse 44 (14) 4 (17) 46 (14) 3 (10) 11 (4) 0.12 (0.71) 19 (6) 1 (3)
Counsellor 47 (15) 33 (123) 52 (16) 36 (122) 20 (6) 2 (8) 23 (7) 2 (9)
Occupational health providers 35 (11) 3 (12) 44 (13.8) 6 (28) 7 (2) 0.5 (5) 18 (6) 3 (15)
Other providers 61 (19) 39 (254) 73 (23) 33 (143) 21 (7) 5 (44) 18 (6) 3 (15)
Medication 307 (97) 311 (98) 190 (60) 194 (61)
Lost work
Total absence 170 (54) 1240 (2996) 168 (53) 1137 (2643) 55 (17) 119 (440) 50 (16) 143 (906)
Due to illness 91 (29) 924 (2729) 86 (27) 818 (2526) 34 (11) 96 (417) 23 (7) 111 (898)
Total service cost 318 411 (1330) 319 592 (3898) 29 (110) 38 (125)
Total cost, including lost work 1651 (3531) 1730 (3531) 125 (451) 149 (908)
S.D., Standard deviation; GP, general practitioner.
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most serious limitations of this study. Consequently
we do not know whether the recovery rates for partici-
pants in the MoodGYM and control arms continued in
parallel over time or not.
A key disadvantage seems to be that there are limi-
ted ways to maximize retention of participants in an
online study, since engagement relies on individual
initiative and commitment. The delivery of the trial
in a clinical setting or via participants’ physicians
seems to be consistently more effective in terms of
their retention. Pittaway et al. (2009), whose partici-
pants were referred by GPs but whose intervention
took place outside the surgery settings, had a 50%
completion rate. In a general practice-based study of
Beating the Blues, Proudfoot et al. (2004) retained
74% of their sample between baseline and post-
intervention assessment, and in a smaller primary
care sample (n=48) Grime (2004) retained 90% at
follow-up. However, our study was relatively ‘arm’s
length’ and relied on the motivation of participants
without the reinforcement of their clinicians.
Nonetheless, our sample showed greater commit-
ment than the community-based participants in a
MoodGYM trial by Christensen et al. (2006), which
found that only 30% of those individuals who com-
plied with the baseline assessment completed even
one module of the programme. The latter was a self-
selected sample, a diagnosis of depression was not
made and there was no email or telephone contact
with participants. However, the same team undertook
a three-way trial of MoodGYM, BluePages (a
psycho-educational site) and a treatment-as-usual
control (Christensen et al. 2004) – and achieved a
completion rate of 81%.
We found that more participants were lost to
follow-up from the MoodGYM arm than from the con-
trol arm, although this was not signiﬁcant. Christensen
et al. (2004) also found that MoodGYM subjects were
more likely to drop out than participants using
BluePages (25% v. 15%). Such a trend could be due
to the more demanding requirements of the interactive
CBT aspects of MoodGYM with its exercises and
quizzes to complete. This implies a need to screen
for user suitability for CBT, with the provision of
alternative resources for those for whom it is not
suitable.
There may also be scope to inﬂuence potential par-
ticipants’ motivation to comply with the requirements
of cCBT, perhaps through education or by offering
incentives. Tailoring the pace of delivery or the num-
ber of exercises to complete each week to individual
preferences may also help with retention. Com-
puterized intervention packages could probably
increase their appeal by learning from developments
in online marketing.
Conclusion
Although the hypothesis that MoodGYM would have
superior outcomes was not proven, given the large
numbers of employees affected by common mental
health problems, employers stand to gain from further
research in this area, while health providers within
employing organizations and beyond may ﬁnd that
judicious use of online self-help can reduce demand
for face-to-face therapy and cut costs.
Retention is fundamental to the successful take-up of
such interventions, even before their effectiveness can
be rigorously tested. More work is needed to stream-
line the delivery of online resources, and data collected
through this study can be used to inform such
developments.
The scope of online interventions is largely restricted
to common mental disorders broadly deﬁned. Differ-
ent packages may need to be developed for particular
difﬁculties, for example bullying at work or bereave-
ment, both of which can manifest as depression with
or without anxiety.
No adverse outcomes were found from the trial,
which extended over a large number of participants
and nearly 2 years in time. This may be taken to add
to the evidence that online self-help is safe. It seems
likely that different combinations of self-help and pro-
fessional input, in person or online, will suit different
people. What works best for whom is not clear, so it
is reasonable to encourage people to discover for them-
selves whether cCBT can aid their recovery. This study
functions as a demonstration of the strengths and
weaknesses of Internet-based research on psychologi-
cal well-being, one that can serve both as a cautionary
tale and as a platform for new research.
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Registered – created username and provided 
contact details 
n = 862 
Participants accessed website and read the study information page 
n = 9305a
a This number is based on web access logs  
Completed baseline but did not proceed 
to randomization: n = 7   
Completed consent questions 
n = 1950 
Completed screening quiz 1: 
PHQ questions 
n = 1715 
Did not consent: n = 19  
Provided consent but did not complete 
subsequent screening quiz: n = 216  
Positive response to one or more  
exclusion criteria: n = 101  
Important note: Of these 101 users, 67 
went on to register as part of the trial – 
48 completed the baseline quiz and were 
randomized (included below), 23 
completed the 6-week follow-up quiz and 
20 completed the 12-week follow-up 
No exclusion criteria but did not continue 
to complete registration: n = 215  
Ineligible based on PHQ: n = 460  
Eligible on PHQ but did not complete 
subsequent screening quiz 2: n = 144  
Completed baseline quiz 
n = 644 
Randomized 
n = 637 
MoodGYM, baseline 
n = 318 
(A = 198, B = 49, C = 71) 
Control, baseline 
n = 319 
(A = 195, B = 51, C = 73) 
Control, 6-week follow-up 
n = 188 
(A = 108, B = 34, C = 46) 
MoodGYM, 6-week follow-up 
n = 171 
(A = 97, B = 34, C = 40) 
Control, 12-week follow-up 
n = 129 
(A = 78, B = 26, C = 25) 
MoodGYM, 12-week follow-up 
n = 102 
(A = 70, B = 16, C = 16) 
Completed screening quiz 2: 
Brain injury or stroke; current CBT treatment; treatment for 
bipolar disorder 
n = 1111 
PHQ-9, Patient Health Questionnaire-9; CBT, cognitive behavioural therapy; A, communications sector; B, transport sector;
C, health sector.
Appendix 1. CONSORT diagram
Computerized CBT for depressive symptoms 751
References
ANU (2012). MoodGYM: Welcome (https://://moodgym.anu.
edu.au/welcome). Australia National University. Accessed
3 December 2012.
Beecham J, Knapp M (2001). Costing psychiatric
interventions. In Measuring Mental Health Needs, 2nd edn
(ed. G. Thornicroft), pp. 200–224. Royal College of
Psychiatrists: London.
Brooks RG, Jendteg S, Lindgren B, Persson U, Björk S
(1991). EuroQol: health-related quality of life measurement.
Results of the Swedish questionnaire exercise. Health Policy
18, 37–48.
Christensen H, Grifﬁths K, Jorm A (2004). Delivering
interventions for depression by using the Internet:
randomised controlled trial. British Medical Journal 328, 265.
Christensen H, Grifﬁths KM, Mackinnon AJ, Brittliffe K
(2006). Online randomized controlled trial of brief and full
cognitive behaviour therapy for depression. Psychological
Medicine 36, 1737–1746.
Curtis L (2010). Unit Costs of Health and Social Care. Personal
Social Services Research Unit: Canterbury.
Department of Health (2007). Improving Access to Psychological
Therapies (IAPT) Programme: Computerised Cognitive
Behavioural Therapy (cCBT) Implementation Guidance.
Department of Health: London.
Dolan P, Gudex C, Kind P, Williams A (1995). A Social Tariff
for EuroQol: Results From a UK General Population Study.
Centre for Health Economics York Discussion Paper no. 138.
Centre for Health Economics: York.
Evans C, Connell J, Barkham M, Margison F, McGrath G,
Mellor-Clark J, Audin K (2002). Towards a standardised
brief outcome measure: psychometric properties and utility
of the CORE-OM. British Journal of Psychiatry 180, 51–60.
Grime PR (2004). Computerized cognitive behavioural
therapy at work: a randomized controlled trial in
employees with recent stress-related absenteeism.
Occupational Medicine 54, 353–359.
Kroenke K, Spitzer RL (2002). The PHQ-9: a new depression
and diagnostic severity measure. Psychiatric Annals 32,
509–521.
Lerner D, Adler DA, Chang H, Berndt ER, Irish JT,
Lapitsky L, Hood MY, Reed J, Rogers WH (2004). The
clinical and occupational correlates of work productivity
loss among employed patients with depression. Journal of
Occupational and Environmental Medicine 46, S46–S55.
Mackinnon A, Grifﬁths KM, Christensen H (2008).
Comparative randomised trial of online cognitive–
behavioural therapy and an information website for
depression: 12 month outcomes. British Journal of Psychiatry
192, 130–134.
Mundt JC, Marks IM, Shear MK, Greist JH (2002). The Work
and Social Adjustment Scale: a simple measure of
impairment in functioning. British Journal of Psychiatry 180,
461–464.
National Institute for Clinical Excellence (2006).
Computerised Cognitive Behaviour Therapy for Depression
and Anxiety: Review of Technology Appraisal 51. NICE:
London.
Pittaway S, Cupitt C, Palmer D, Arowobusoye N, Milne R,
Holttum S, Pezet R, Patrick H (2009). Comparative clinical
feasibility study of three tools for delivery of cognitive
behaviour therapy for mild to moderate depression and
anxiety provided on a self-help basis. Mental Health in
Family Medicine 6, 145–154.
Proudfoot J, Ryden C, Everitt B, Shapiro DA, Goldberg D,
Mann A, Tylee A, Marks I, Gray JA (2004). Clinical
efﬁcacy of computerised cognitive behavioural therapy
for anxiety and depression in primary care: randomised
controlled trial. British Journal of Psychiatry 18, 46–54.
Sanderson K, Tilse E, Nicholson J, Oldenburg B, Graves N
(2007). Which presenteeism measures are more sensitive to
depression and anxiety? Journal of Affective Disorders 101,
65–74.
Sarrami P, Schneider J, Assareh N (2011). Meta-review of the
effectiveness of computerised CBT in treating depression.
BMC Psychiatry 11, 131.
Schulz KF, Grimes DA (2002). Generation of allocation
sequences in randomised trials: chance, not choice.
Lancet 359, 515–519.
Singleton N, Bumpstead R, O’Brien M, Lee A, Meltzer H
(2001). Psychiatric Morbidity Among Adults Living in Private
Households, 2000. Summary Report. Ofﬁce for National
Statistics: London.
Spitzer RL, Kroenke K, Williams JB, Lowe B (2006).
A brief measure for assessing generalized anxiety
disorder: the GAD-7. Archives of Internal Medicine 166,
1092–1097.
Trajectory (2010). Mental Health: Still the Last Workplace
Taboo? (http://www.tacklementalhealth.org.uk/_assets/
documents/mental_health_report_2010.pdf). Accessed 24
May 2012.
752 R. Phillips et al.
